skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
CHP-NY-ESO-1 Peptide Vaccine IMF-001 (Code C62598)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: CHP-NY-ESO-1 Peptide Vaccine IMF-001

Definition: A peptide cancer vaccine containing nanoparticles of cholesteryl hydrophobized pullulan (CHP) complexed with the cancer-testis antigen NY-ESO-1 protein, with potential immunostimulating and antineoplastic activities. Upon administration, CHP-NY-ESO-1 peptide vaccine IMF-001 may stimulate the host immune system to mount a humoral and cytotoxic T-cell response against tumor cells expressing NY-ESO-1 antigen, resulting in tumor cell lysis. The self-aggregating CHP, composed of a pullulan backbone and cholesterol branches, forms stable colloidal nanoparticles in water. NY-ESO-1, an antigen found in normal testis, is upregulated in various cancers, including bladder, breast, hepatocellular, melanoma, and prostate cancers.

Display Name: CHP-NY-ESO-1 Peptide Vaccine IMF-001

Label: CHP-NY-ESO-1 Peptide Vaccine IMF-001

NCI Thesaurus Code: C62598 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1831881  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Cholesteryl Pullulan-NY-ESO-1 Vaccine IMF-001
CHP-NY-ESO-1 Peptide Vaccine IMF-001

External Source Codes: 
PDQ Closed Trial Search ID 489132
PDQ Open Trial Search ID 489132 (check for NCI PDQ open clinical trial info)
UMLS CUI C1831881

Other Properties:
     Name Value (qualifiers indented underneath)
code C62598
Contributing_Source CTRP
Legacy_Concept_Name CHP-NY-ESO-1_Peptide_Vaccine
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom